Efficacy and tolerability of indiplon in adults with chronic insomnia: Results from two double-blind, placebo-controlled trials

被引：0
|
作者：
Klee, B.
Keohane, D.
Bell, J.
Farber, R.
机构：
[1] Pfizer Inc, New York, NY USA
[2] Neurosci Biosci Inc, San Diego, CA USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability of indiplon in primary insomnia: Results of a double-blind, placebo-controlled, 4-week trial
    Lankford, D.
    Klee, B.
    Kean, Y.
    Farber, R.
    [J]. SLEEP, 2006, 29 : A256 - A256
  • [2] Efficacy and tolerability of Indiplon-MR in elderly patients with chronic insomnia: Results of a double-blind, placebo-controlled, 2-week trial
    Lankford, J
    Lydiard, R
    Walsh, JK
    Seiden, D
    Jochelson, P
    [J]. SLEEP, 2005, 28 : A230 - A230
  • [3] Long term efficacy and tolerability of indiplon-ir in the treatment of chronic insomnia: Results of a double-blind, placebo-controlled 3-month study
    Scharf, MB
    Black, J
    Hull, S
    Mahowald, M
    Moscovitch, A
    Farber, R
    Jochelson, P
    [J]. SLEEP, 2005, 28 : A229 - A229
  • [4] Efficacy and Tolerability of Modified-Release Indiplon in Elderly Patients With Chronic Insomnia: Results of a 2-Week Double-Blind, Placebo-Controlled Trial
    Lydiard, R. Bruce
    Lankford, D. Alan
    Seiden, David J.
    Landin, Rick
    Farber, Robert
    Walsh, James K.
    [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2006, 2 (03): : 309 - 315
  • [5] Efficacy and tolerability of indiplon in older adults with primary insomnia: A two-week, double-blind study
    Farber, R
    Walsh, JK
    Roth, T
    [J]. NEUROLOGY, 2006, 66 (05) : A78 - A78
  • [6] Sleep laboratory assessment of indiplon in primary insomnia: Results of a double-blind, placebo-controlled, crossover trial
    Rosenberg, R.
    Hull, S.
    Cohn, M.
    Kean, Y.
    Farber, R.
    [J]. SLEEP, 2006, 29 : A257 - A257
  • [7] Long-term nightly treatment with indiplon in adults with chronic insomnia: Results of a double-blind, placebo-controlled, 3-month study
    Farber, R
    Scharf, MB
    Black, J
    Landin, R
    [J]. NEUROLOGY, 2006, 66 (05) : A9 - A9
  • [8] Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials
    Huang, Zhaoyang
    Zhan, Shuqin
    Chen, Chunyan
    Zhang, Ruoxi
    Zhou, Yanling
    He, Jingjing
    Lin, Zhaocun
    Bao, Cungang
    Zhu, Shuangpeng
    Zhao, Jianjun
    Zhang, Shengan
    Jiang, Yu
    Wang, Yuping
    [J]. SLEEP, 2024, 47 (02)
  • [9] Efficacy and tolerability of indiplon in older adults with primary insomnia: A two-week, double-blind study.
    Moscovitch, A
    Walsh, JK
    Bell, J
    Farber, R
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S121 - S122
  • [10] Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia
    Kohsaka, Masako
    Kanemura, Takashi
    Taniguchi, Mitsutaka
    Kuwahara, Hiroo
    Mikami, Akira
    Kamikawa, Kunihisa
    Uno, Hideki
    Ogawa, Atsushi
    Murasaki, Mitsukuni
    Sugita, Yoshiro
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (10) : 1389 - 1397
12345